tailieunhanh - The use of PanDrugs to prioritize anticancer drug treatments in a case of TALL based on individual genomic data

Acute T-cell lymphoblastic leukaemia (T-ALL) is an aggressive disorder derived from immature thymocytes. The variability observed in clinical responses on this type of tumours to treatments, the high toxicity of current protocols and the poor prognosis of patients with relapse or refractory make it urgent to find less toxic and more effective therapies in the context of a personalized medicine of precision. | The use of PanDrugs to prioritize anticancer drug treatments in a case of TALL based on individual genomic data

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN